Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Gastroenterology Research|November 10, 2025
Risk Stratification and Contemporary Predictors of Survival in Hepatocellular Carcinoma Treated With Transarterial RadioembolizationDeepak Sherpally, Parthib Das, Fode Tounkara, et al.
Cell Reports|December 21, 2022
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosisVijaya Bharti, Reese Watkins, Amrendra Kumar, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2023
Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumorsArjun Mittra, Geraldine H O' Sullivan Coyne, Jennifer Zlott, et al.
Cancer Research Communications|October 17, 2025
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)Mamta Parikh, Nataliya V Uboha, Naoko Takebe, et al.
JCO Precision Oncology|July 16, 2025
Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid TumorsGeraldine O'Sullivan Coyne, Khanh T Do, Shivaani Kummar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2025
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical TrialChunjie Li, Anne M Noonan, John Hays, et al.
International Journal of Molecular Sciences|August 29, 2024
Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and OutcomesAshish Manne, Ashwini Esnakula, Ankur Sheel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2021
Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid TumorsNaoko Takebe, Abdul Rafeh Naqash, Geraldine O'Sullivan Coyne, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 7, 2024
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United StatesKathryn Lurain, Talal El Zarif, Ramya Ramaswami, et al.
Journal of the National Cancer Institute|August 11, 2023
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary TumorsTalal El Zarif, Amin H Nassar, Gregory R Pond, et al.
Pageof 4